Abiopharma

🔍 Binstein Richard (Executive)

Company: U S PHYSICAL THERAPY INC /NV (USPH)

Report Date: 2026-03-06

Detailed Transactions and Holdings:

• Sold 3,000 shares of Common Stock at $81.64 per share (Direct)
  Date: 2026-03-06 | Code: S | equity_swap_involved: false | shares_owned_after: 24,867.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Includes 21,070 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restriction lapse as to 1,870 shares will vest on each of May 20, 2026, August 20, 2026 and November 20, 2026, 1,876 shares will vest on March 6, 2027, 1,636 shares will vest on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,640 shares will vest on March 6, 2028, 1,130 shares will vest on each of May 20, 2028, August 20, 2028, and November 20, 2028, 1,134 shares will vest on March 6, 2029, 624 shares will vest on each of May 20, 2029, August 20, 2029, and November 20, 2029 and 640 shares will vest on March 6, 2030, if he is an employee of the Company on those dates.